Standard Capital Markets gains on getting nod to raise Rs 401.50 crore via NCDS
![](https://portfolio.investmentguruindia.com/uploads/news/NBFC.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Standard Capital Markets is currently trading at Rs. 1.68, up by 0.02 points or 1.20% from its previous closing of Rs. 1.66 on the BSE.
The scrip opened at Rs. 1.68 and has touched a high and low of Rs. 1.70 and Rs. 1.60 respectively. So far 8763295 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 1 has touched a 52 week high of Rs. 3.52 on 27-Feb-2024 and a 52 week low of Rs. 1.15 on 25-Aug-2023.
Last one week high and low of the scrip stood at Rs. 1.73 and Rs. 1.44 respectively. The current market cap of the company is Rs. 292.37 crore.
The promoters holding in the company stood at 17.74%, while Non-Institutions held 82.26% stake in the company.
Standard Capital Markets has received approval for the issuance of Secured, Unlisted, Unrated, Redeemable Non-convertible Debentures (NCDs) having a face value of Rs 10,00,000 each, aggregating up to an amount of Rs 401.50 crore in one or more tranches on a Private Placement basis. The Board of Directors of the company in its Meeting held on July 2, 2024 have, inter alia, considered and approved the same.
Standard Capital Markets is a Non-Banking Financial Company.
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)